30.71

0.13% 0.04

Baxter International Inc (BAX)

Overview News Price History Option Chain Financials Why BAX Down? Discussions Forecast Stock Split Dividend History

Baxter International Inc stock is traded at $30.71, with a volume of 4.17M. It is up +0.13% in the last 24 hours and down -8.74% over the past month. Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.

Previous Close:

$30.67

Open:

$31.06

24h Volume:

4.17M

Relative Volume:

0.87

Market Cap:

$15.66B

Revenue:

$17.28B

Net Income/Loss:

$108.00M

P/E Ratio:

153.55

EPS:

0.2

Net Cash Flow:

$391.00M

1W Performance:

+1.62%

1M Performance:

-8.74%

6M Performance:

-14.39%

1Y Performance:

-16.80%

1-Day Range:

$30.23

$31.25

1-Week Range:

$30.09

$32.60

52-Week Range:

$26.25

$40.49

Baxter International Inc Stock (BAX) Company Profile

Name

Baxter International Inc

Sector

Healthcare (1152)

Industry

Medical Instruments & Supplies (64)

Phone

(847) 948-2000

Address

ONE BAXTER PKWY, DEERFIELD, IL

Employee

60,000

Twitter

@baxter_intl

Next Earnings Date

2024-11-08

Latest SEC Filings

BAX's Discussions on Twitter

Compare BAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BAX Baxter International Inc	30.71	15.66B	17.28B	108.00M	391.00M	0.20
ISRG Intuitive Surgical Inc	529.42	184.44B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.78	58.89B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	98.30	46.96B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	239.95	34.59B	5.02B	1.31B	1.56B	8.91
COO The Cooper Companies, Inc.	82.30	16.16B	3.90B	392.30M	288.10M	1.95

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Resumed	Goldman	Buy
Feb-24-25	Upgrade	Argus	Hold → Buy
Feb-20-25	Resumed	Barclays	Overweight
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-30-24	Initiated	Goldman	Neutral
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-30-23	Resumed	Morgan Stanley	Equal-Weight
Mar-29-23	Initiated	UBS	Neutral
Jan-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-05-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-03-23	Downgrade	BofA Securities	Buy → Neutral
Dec-19-22	Downgrade	JP Morgan	Overweight → Neutral
Dec-15-22	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Hold
Jun-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-04-22	Downgrade	Goldman	Neutral → Sell
Mar-02-22	Resumed	BofA Securities	Buy
Feb-18-22	Reiterated	KeyBanc Capital Markets	Overweight
Feb-18-22	Reiterated	Morgan Stanley	Overweight
Feb-18-22	Reiterated	Raymond James	Outperform
Feb-18-22	Reiterated	Stifel	Buy
Feb-18-22	Reiterated	UBS	Neutral
Feb-18-22	Reiterated	Wells Fargo	Overweight
Feb-11-22	Initiated	Goldman	Neutral
Jan-07-22	Resumed	Citigroup	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-21	Upgrade	Cowen	Market Perform → Outperform
Sep-03-21	Upgrade	Barclays	Equal Weight → Overweight
May-25-21	Initiated	Barclays	Equal Weight
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral
Jan-06-21	Downgrade	UBS	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Oct-01-20	Upgrade	Citigroup	Neutral → Buy
Sep-04-20	Downgrade	Argus	Buy → Hold
Jun-24-20	Initiated	Oppenheimer	Outperform
Mar-19-20	Upgrade	Stifel	Hold → Buy
Mar-18-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-05-20	Initiated	Citigroup	Neutral
Feb-13-20	Initiated	Goldman	Buy
Jan-02-20	Upgrade	Evercore ISI	In-line → Outperform
Dec-17-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-26-19	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-08-19	Downgrade	Evercore ISI	Outperform → In-line
Jan-02-19	Upgrade	Citigroup	Neutral → Buy
Jan-02-19	Upgrade	Morgan Stanley	Underweight → Overweight
Nov-02-18	Upgrade	Argus	Hold → Buy
Oct-16-18	Initiated	Barclays	Underweight
May-17-18	Resumed	Piper Jaffray	Overweight
Feb-06-18	Reiterated	Citigroup	Neutral
Jan-03-18	Initiated	Evercore ISI	Outperform
Jan-03-18	Upgrade	Raymond James	Mkt Perform → Outperform

View All

Baxter International Inc Stock (BAX) Latest News

May 02, 2025

Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica

May 02, 2025

Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat

May 02, 2025

Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus

May 02, 2025

Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com

May 02, 2025

Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com

May 02, 2025

JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com

May 02, 2025

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st

May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025